Perioperative β blockade: where do we go from here?

The Lancet

Volumn 371, Issue 9627, 2008, Pages 1813-1814

  Fleisher, Lee A ^a   Poldermans, Don ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; METOPROLOL SUCCINATE; PLACEBO;

ANGINA PECTORIS; ARTERY DISEASE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; CORONARY ARTERY DISEASE; HEART ARREST; HEART FAILURE; HEART HEMODYNAMICS; HEART INFARCTION; HUMAN; HYPERTENSION; PRIORITY JOURNAL; STROKE; TACHYCARDIA;

EID: 44549085530     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60662-5     Document Type: Note

References (10)

1. POISE Study Group. Effect of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet (2008) 10.1016/S0140-6736(08)60601-7 published online May 13.
2. Fleisher L., Beckman J., Brown K., et al. ACC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 50 (2007) 1707-1732
3. Leapfrog Group http://www.leapfroggroup.org (accessed May 6, 2008).
4. Cruickshank J. Beta-blockers continue to surprise us. Eur Heart J 21 (2000) 354-364
5. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
6. Lee T., Marcantonio E., Mangione C., et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100 (1999) 1043-1049
7. Poldermans D., Boersma E., Bax J., et al., for the Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo Study Group. Bisoprolol reduces perioperative cardiac death and myocardial infarction in high-risk patients undergoing major vascular surgery. N Engl J Med 341 (1999) 1789-1795
8. Poldermans D., Bax J., Schouten O., et al., for the Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo Study Group. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?. J Am Coll Cardiol 48 (2006) 964-969
9. Poldermans D, Hoeks S, Feringa H. Preoperative risk assessment and risk reduction prior to surgery. J Am Coll Cardiol (in press).
10. Smith Jr. S., Allen J., Blair S., et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113 (2006) 2363-2372